In summary, our data indicate that USP53 inhibits the inactivation of the NF‐κB pathway by reducing the ubiquitination of IκBα to further inhibit ccRCC proliferation and metastasis. The gene discussed is NFKBIA; the disease is nonpapillary renal cell carcinoma.